Treace Medical Concepts prices $100M offering

  • Treace Medical Concepts (NASDAQ:TMCI) prices an underwritten public offering of ~4.76M shares at a public offering price of $21.00 per share.
  • Underwriters have a 30-day option to purchase up to an additional 714,285 shares.
  • Gross proceeds are expected to be ~$100M, excluding any exercise of the underwriters’ option to purchase additional shares.
  • The offering is expected to close February 10, 2023.
  • Net proceeds to be deployed for general corporate purposes, including research and development and sales and marketing activities, general and administrative matters and capital expenditures.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.